Discounted Cash Flow
Encompass Health Corp.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $3.6b | $247.6m | $427.8m | 6.8% | $2.77 |
| 2017 | $3.9b (7.5%) | $256.3m (3.5%) | $431.4m (0.8%) | 6.5% (-3.7%) | $2.73 (-1.4%) |
| 2018 | $4.3b (9.1%) | $292.3m (14.0%) | $507.9m (17.7%) | 6.8% (4.5%) | $2.98 (9.2%) |
| 2019 | $4.6b (7.7%) | $358.7m (22.7%) | $262.9m (-48.2%) | 7.8% (14.0%) | $3.65 (22.5%) |
| 2020 | $4.6b (0.9%) | $284.2m (-20.8%) | $308.7m (17.4%) | 6.1% (-21.4%) | $2.87 (-21.4%) |
| 2021 | $5.1b (10.3%) | $412.2m (45.0%) | $186.9m (-39.5%) | 8.0% (31.5%) | $4.15 (44.6%) |
| 2022 | $4.3b (-15.1%) | $271.0m (-34.3%) | $141.0m (-24.6%) | 6.2% (-22.6%) | $2.72 (-34.5%) |
| 2023 | $4.8b (10.4%) | $352.0m (29.9%) | $267.7m (89.9%) | 7.3% (17.6%) | $3.51 (29.0%) |
| 2024 | $5.4b (11.9%) | $455.7m (29.5%) | $360.3m (34.6%) | 8.5% (15.7%) | $4.53 (29.1%) |
| 2025 | $5.9b (10.5%) | $566.2m (24.2%) | $439.2m (21.9%) | 9.5% (12.5%) | $5.62 (24.1%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.